Zhong Nanshan disclosed an important news about the new vaccine

◎   Science and Technology Daily reporter Ye Qing said, “the main problem we are facing is the mutation of the new coronavirus

.

The mutated strains are from Britain, Brazil, Nigeria, South Africa and other places

.

For the b1351 mutant strain in South Africa, the efficacy of the whole virus inactivated vaccine in use has been reduced

.

Now we are working hard to develop a vaccine against the mutant strain

.

” Zhong Nanshan, academician of the Chinese Academy of engineering, reported online at the 2021 frontier forum of Medical Sciences of the Chinese Academy of Engineering in Guangzhou on the 24th

.

Zhong Nanshan checked the X-ray film in the consulting room of the First Affiliated Hospital of Guangzhou Medical University (taken on August 2, 2018)

.

  Source: what is the novel coronavirus pneumonia Deng Hua, who is suffering from a novel coronavirus pneumonia? People who are in the same health condition receive the same treatment, some of them deteriorate or even die, but some of them are getting better soon? It may be closely related to genetic susceptibility Zhong Nanshan said that he is organizing forces from all walks of life, hoping to find the susceptibility gene of NCV among Asians, especially Chinese, through large-scale population screening

.

He pointed out that there are still many unsolved problems in the world’s novel coronavirus vaccine, such as how long does the protection last after the vaccine is given? Two or even three times, can we further improve the protection rate of the virus? These are all problems that need to be solved“ At present, there are nearly 50 kinds of vaccines in the research and development process in China, and there are more than 200 kinds of vaccines in the world

.

If we can find a comprehensive, universal and universal vaccine research and development index, we can make more efforts to use it on the blade

.

” Zhong Nanshan said

.

In view of the side effects caused by the vaccination of Xinguan vaccine in the world, for example, more than 30 normal people in Germany, Austria and the United Kingdom have developed thromboembolism and thrombocytopenia after being vaccinated with adenovirus vaccine

.

Zhong Nanshan expressed great concern“ Why do these people have these phenomena and what factors are related to them? How to avoid such side effects? These are the problems that need to be solved in front of us

.

” He said

.

Source: Science and technology daily editor: Wang Yu reviewed by: Zhu Li final reviewed by: He Yi.

.